levels to increase by more than twofold (P Ͻ 0.01). This increase was blocked by losartan (AT1 receptor blocker) but not PD-123319 (AT2 receptor antagonist). Apocynin (a NOX inhibitor) decreased O 2 Ϫ by 86% (P Ͻ 0.01), whereas oxypurinol (a xanthine oxidase inhibitor) and NS-398 (a cyclooxygenase-2 inhibitor) had no significant effect. The NOX-dependent increase in O 2 Ϫ was due to the NOX2 isoform; a short interfering (si)RNA against NOX2 blunted ANG II-induced increases in O 2 Ϫ , whereas the NOX4/siRNA did not. Finally, we found that inhibiting the Rac1 subunit of NOX blunted ANG II-induced O 2 Ϫ production in NOX4/siRNA-treated cells but did not further decrease it in NOX2/siRNA-treated cells. Our results indicate that ANG II stimulates O 2 Ϫ production in the MD primarily via AT1-dependent activation of NOX2. Rac1 is required for the full activation of NOX2. This pathway may be an important component of ANG II enhancement of tubuloglomerular feedback.
Ϫ ) and angiotensin II (ANG II). We have reported that NaCl-induced O 2 Ϫ in the MD is produced by the NOX2 isoform of NADPH oxidase (NOX); however, the source of ANG II-induced O 2 Ϫ in MD is unknown. Thus we determined the pathways by which ANG II increased O 2 Ϫ in the MD by measuring O 2 Ϫ in ANG II-treated MMDD1 cells, a MD-like cell line. ANG II caused MMDD1 O 2 Ϫ levels to increase by more than twofold (P Ͻ 0.01). This increase was blocked by losartan (AT1 receptor blocker) but not PD-123319 (AT2 receptor antagonist). Apocynin (a NOX inhibitor) decreased O 2 Ϫ by 86% (P Ͻ 0.01), whereas oxypurinol (a xanthine oxidase inhibitor) and NS-398 (a cyclooxygenase-2 inhibitor) had no significant effect. The NOX-dependent increase in O 2 Ϫ was due to the NOX2 isoform; a short interfering (si)RNA against NOX2 blunted ANG II-induced increases in O 2 Ϫ , whereas the NOX4/siRNA did not. Finally, we found that inhibiting the Rac1 subunit of NOX blunted ANG II-induced O 2 Ϫ production in NOX4/siRNA-treated cells but did not further decrease it in NOX2/siRNA-treated cells. Our results indicate that ANG II stimulates O 2 Ϫ production in the MD primarily via AT1-dependent activation of NOX2. Rac1 is required for the full activation of NOX2. This pathway may be an important component of ANG II enhancement of tubuloglomerular feedback.
NAD(P)H oxidase; isoforms; tubuloglomerular feedback
MACULA DENSA (MD) cells are specialized epithelial cells located at the end of the thick ascending limb that is adjacent to its glomerulus. These cells sense increases in luminal NaCl delivery, which triggers signals that constrict afferent arterioles and decrease glomerular filtration rate (GFR) (a process called tubuloglomerular feedback; TGF) and renin release (37) . In this manner, they play an important role in the regulation of the renal microcirculation and maintenance of salt and water homeostasis (32, 35, 46) .
Because of their importance in the short-and long-term regulation of renal hemodynamics and salt and water balance, TGF responses and MD-mediated renin release are tightly regulated. This is achieved via the coordinated actions of various factors including angiotensin II (ANG II), superoxide (O 2 Ϫ ), and nitric oxide (NO) (22, 23, 34) . In addition, interactions between these factors may be critical in determining the net effect on GFR; for instance, O 2 Ϫ scavenges NO, which results in enhancement of the TGF response (23) . Factors that increase O 2 Ϫ levels have the potential to augment TGF responses and consequently lead to abnormal renal salt handling and hypertension. Thus it is important to understand the sources and mechanism(s) that alter O 2 Ϫ production in the MD. In this respect, it is interesting to note that ANG II (which enhances the TGF response) causes salt-sensitive hypertension, mediated in part by oxidative stress (25, 28) . This raises the possibility that the hypertensive effects of ANG II may be due in part to enhanced O 2 Ϫ production in the MD. Recently, we found the isoforms of NADPH oxidase (NOX) expressed in the MD are NOX2 and NOX4 (48) . However, the mechanisms by which ANG II increases O 2 Ϫ production in the MD are incompletely understood. In the present study, we investigated mechanisms by which ANG II increased O 2 Ϫ production in a MD-like cell line, MMDD1 cells. We found that ANG II-induced activation of ANG II type 1 (AT 1 ) receptors on MMDD1 cells increased O 2 Ϫ predominantly via the NOX2 isoform of NOX and that the full activation of NOX2 required the presence of GTPase-Rac, a molecular switch for phagocytic NOX.
METHODS
All experiments were approved by the University of Mississippi Medical Center Animal Care and Use Committee before any procedures were performed.
Chemicals. All reagents for cell culture were purchased from Invitrogen (Carlsbad, CA). All chemicals were purchased from Sigma (St. Louis, MO), except for NSC23766 which was purchased from EMD (Gibbstown, NJ).
Cell culture. Experiments were undertaken in MMDD1 cells, a MD-like renal epithelial cell line (kindly provided by Dr. J. Schnermann, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD), which express well-known MD markers such as cyclooxygenase-2 (COX-2), neuronal nitric oxide synthase (nNOS), renal outer medullary K ϩ channel (ROMK), and Na ϩ -K ϩ -2Cl cotransporter (NKCC2) (14, 30, 47) . In the present study, we did not characterize all of the markers except our interested targets. MMDD1 cells at passages 20 -25 were cultured in DMEM nutrient mixture-Ham's F-12 (supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 g/ml streptomycin) and incubated in a humidified atmosphere of 95% room air-5% CO2 at 37°C.
Measurement of O 2 Ϫ with lucigenin. We measured O 2 Ϫ production in the MMDD1 cell line using a lucigenin-enhanced chemiluminescence assay (4 were then added to each of the samples and placed in 5-ml polystyrene tubes. The dose of ANG II used in this study was based on our previous study in which we found it induced maximal increases in cell Ca 2ϩ and NO in the MD (21) . The doses of the inhibitors chosen were based on previous studies by us (21) , for the AT1 and AT2 antagonists, or others (9, 11, 17, 27, 33, 38, 41) . We used the maximum inhibitory concentrations of each inhibitor.
After the samples had been allowed to equilibrate for 30 min at 37°C, the tubes were placed in a Sirius luminometer (Berthold Detection Systems, Pforzheim, Germany). Luminescence was measured for 10 s with a delay of 5 s. At the end of each experiment, the cell-permeant O 2 Ϫ scavenger Tiron (10 mM) was added to remove the O 2 Ϫ , after which background luminescence was measured. Because the luminescence is stable within the time frame of these experiments, the difference between the pre-and post-Tiron luminescent signals was used to determine the O 2 Ϫ levels [expressed as relative units (RLU) · s Ϫ1 ·10 5 cells Ϫ1 ]. Preparations for short interfering RNA. The short interfering (si)RNAs were designed and synthesized by Santa Cruz Biotechnology (Santa Cruz, CA). The transfection of the siRNA was performed using TransMessenger transfection reagent from Qiagen (Germantown, MD) according to the manufacturer's instructions. Scrambled siRNA were synthesized and used as negative controls. Twenty-four hours before transfection, MMDD1 were transferred onto six-well plates and transfected with 2 g of each siRNA duplex using TransMessenger transfection reagent for 3 h in medium devoid of serum and antibiotics. The MMDD1 cells were then washed once with PBS and grown in complete medium. Gene silencing was monitored by measuring RNA after incubation for 24 h. These samples were then stimulated with 10 Ϫ6 M ANG II in the presence and absence of NSC23766 (5 ϫ 10 Ϫ5 M), and O 2 Ϫ was measured with the lucigenin chemiluminescence assay as mentioned above. Viability of the cells was confirmed by morphological criteria and their ability to transport calcein normally (data not shown).
Statistics. Data are means Ϯ SE. We used analysis of variance plus the Fisher least significant difference post hoc test for multiple comparison analysis and, when appropriate, the Student's t-test to detect whether ANG II or the various inhibitors affected O 2 Ϫ levels. A P value Ͻ0.05 was considered significant.
RESULTS

ANG II increases O 2
Ϫ production via activation of its AT 1 receptor. We first determined whether ANG II induced O 2 Ϫ production in MMDD1 cells and, if so, which receptor subtype it was working through. As shown in Fig. 1 either NOX2 or NOX4; we only studied these isoforms because we had previously demonstrated that they were the only ones present on MD cells (48) . Figure 3 demonstrated the efficacy of the NOX2/siRNA and NOX4/siRNA in reducing their target NOX mRNA. Figure 3 , A and B, shows the NOX2 and NOX4 mRNA levels, respectively, in MMDD1 cells treated with scrambled, NOX2/siRNA, or NOX4/siRNA. NOX2 mRNA levels were decreased by the NOX2/siRNA by 87 Ϯ 1.4% of the scrambled siRNA levels, and NOX4 mRNA levels were decreased by NOX4/siRNA by 82 Ϯ 2.6%. In NOX4/ siRNA-treated cells, NOX2 mRNA was 95.4 Ϯ 3.7% compared with cells treated with scrambled siRNA. In NOX2/ siRNA-treated cells, NOX4 mRNA was 97.5 Ϯ 4.1% compared with the control. These results thus showed that the 24-h exposures to either NOX2/siRNA or NOX4/siRNA were both very effective at decreasing their respective NOX mRNA levels without affecting the levels of the other isoenzyme. Therefore, we next used these siRNAs to determine the contribution of each NOX isoform to ANG II-induced O 2 Ϫ production. The effects of knocking down either NOX2 or NOX4 mRNA on ANG II-induced O 2 Ϫ production in MMDD1 cells are shown in Fig. 4 ANG II increased O 2 Ϫ production via Rac1-dependent activation. Activation of some isoforms of NOX requires translocation of a small GTP-binding protein, Rac, to the cell membrane. Rac2 is mainly expressed in phagocytes and is the most relevant Rac GTPase for NOX2 activation. Rac1 is expressed ubiquitously and is the main Rac GTPase for some activation of NOXs in nonphagocytic cells (16) . Therefore, we tested whether inhibiting Rac1 with NSC23766 would prevent ANG II-induced O 2 Ϫ production in MMDD1 cells. We hypothesized that the Rac1 inhibitor would not affect ANG II-induced O 2 Ϫ production in NOX2/siRNA-treated cells (since NOX2 would already be reduced) but would prevent it in the NOX4/ siRNA-treated cells (since NOX2 activity was intact in these cells). As shown in Fig. 5 at left, ANG II-induced O 2 Ϫ generation was already blunted in the NOX2/siRNA-treated cells (which is consistent with our data in Fig. 4 ). The addition of the Rac1 inhibitor in these cells had no further effect on O 2 Ϫ levels, which was 225 Ϯ 65 RLU·s Ϫ1 ·10 5 cells Ϫ1 with Rac1 inhibitor, demonstrating that Rac1 inhibition had no effect when NOX2 was already inhibited. In contrast, inhibiting Rac1 significantly reduced ANG II-induced O 2 Ϫ production in the NOX4/siRNA cells; ANG II only increased O 2 Ϫ levels to 262 Ϯ 86 RLU·s Ϫ1 ·10 5 cells Ϫ1 (P Ͻ 0.05). These results indicated that ANG II increased O 2 Ϫ production in MMDD1 cells in large part via Rac1-dependent activation of NOX2.
DISCUSSION
TGF is a key regulator of GFR and salt excretion and thus is important in the regulation of salt homeostasis and blood pressure. For this system to maintain appropriate salt homeostasis throughout a wide range of conditions, it must adapt and adjust its responsiveness both acutely and chronically. One of the key factors in regulating responsiveness of the TGF system is ANG II (34) , which may exert its effect via several mechanisms, including by increasing the O 2 Ϫ levels. In the present study, we found that ANG II directly increased the production of O 2 Ϫ in a MD-like cell line via AT 1 receptordependent activation of the NOX2 isoform of NOX.
ANG II exerts its effects via two receptor subtypes, AT 1 and AT 2 . The AT 1 receptor stimulates transport and causes vasoconstriction, whereas the AT 2 receptor inhibits transport and causes vasodilation (8, 40) . MD cells have been found to express AT 1 ; consequently, the possibility that ANG II could enhance TGF by affecting MD cell function was proposed and investigated (13) . Direct evidence for this was provided by Wang et al. (43) , who found that ANG II enhanced TGF via activation of AT 1 receptors on the luminal membrane of the MD. Moreover, we previously found that ANG II increased intracellular calcium concentrations in microperfused MD and that this response was blocked by the AT 1 antagonist but not the AT 2 antagonist (21). Thus most of the effects of ANG II on the MD appear to be mediated via the AT 1 receptor. Our present results are consistent with these in that ANG II-induced increases in O 2 Ϫ production in the MMDD1 cells was also blocked by an AT 1 antagonist but not the AT 2 antagonist. Although AT 1A receptor deletion develops salt-sensitive hypertension (24), the mechanism may be via AT 1B receptor. In proximal tubule, picomolar ANG II increases sodium transport; however, micromolar ANG II decreases sodium transport (36) . However, we are unaware of ANG II having a biphasic effect on the MD; ANG II has been shown to stimulate cotransport activity via its AT 1 receptors in the MD at 10 Ϫ12 , 10 Ϫ9 , or 10 Ϫ6 M (although its effect at 10 Ϫ6 M is blunted by activation of the AT 2 receptor) (19) . We used the ANG II dose that had maximal activity in MD cells in our previous study (21) .
There are several potential sources of ANG II-induced O 2 Ϫ generation in the MD, including xanthine oxidase, COX-2, NOX, uncoupled NOS, cytochrome P-450, and mitochondria (3, 7, 45). In our present study, O 2 Ϫ generation during ANG II was inhibited by apocynin, suggesting that NOX is the primary source of ANG II-induced O 2 Ϫ . We previously reported that NOX was also the primary source of O 2 Ϫ produced by isolated microperfused MD during NaCl-induced TGF responses (20) and then found that MMDD1 cells exposed to high NaCl concentrations also increased O 2 Ϫ production via NOX. Thus, together, our results suggest that the TGF response is modulated not only directly by NaCl-induced changes in NOXderived O 2 Ϫ but also indirectly by ANG II-induced activation of NOX. The potential importance of ANG II-induced NOX in the MD was suggested by the micropuncture studies of Nouri et al. (29) , who reduced NOX activity in ANG II-treated rats by knocking down the p22 phox subunit of NOX using siRNA. They found that the p22 phox -siRNA reduced single-nephron GFR and thus speculated that p22 phox /NOX regulated the GFR during ANG II infusion via MD-dependent mechanisms, including TGF. However, because p22 phox is an integral part of all three NOX isoforms found in the kidney, they could not determine which isoform was responsible for the altered responses.
NADPH oxidases consist of seven members [NOX1-NOX5, DUOX1, and DUOX2 (2, 10, 39) , but only the NOX1, NOX2, and NOX4 isoforms are expressed in the adult kidney]. We previously tested for the presence of these three isoforms in the renal cortex and in MD isolated using laser capture microdissection (LCM) (48) . We found that all three isoforms were present in the renal cortex, but only NOX2 and NOX4 were expressed in the LCM-captured MD cells. Likewise, these same two isoforms were expressed in a similar manner in the MMDD1 cells. Because of these similarities and because we cannot effectively knock down NOX2 and NOX4 in isolated MD cells in vivo, we studied the role of each isoform in MD-derived O 2 Ϫ generation in the MMDD1 cells. Using these cells, we previously showed that NOX2 was responsible for NaCl-induced O 2 Ϫ generation (48). Our present study extends previous ones in that we now report that the NOX2 isoform is also the primary source of ANG II-induced O 2 Ϫ generation in MMDD1 cells. Thus both NaCl and ANG II appear to be regulating MD O 2 Ϫ levels in tandem on the same NOX isoform, which may be important in determining how they modulate the TGF responses. Meanwhile, we should point out the differences between cell culture and in vivo situations. For example, we did not separate apical and basolateral sides in the cultured cells, so the NaCl concentration is normal to the basolateral but is high in relation to the apical compared with that in vivo.
Further evidence for the role of NOX2 in ANG II-induced O 2 Ϫ generation in MMDD1 cells comes from the experiments with the Rac1 inhibitor. Activation of NOX2 requires the translocation of two specialized cytosolic proteins, p47 phox and p67 phox , and the small GTP-binding protein Rac to the membrane (1, 5, 6) . Although Rac also may be involved in the activation of NOX1 (18, 31) , it does not seem to be involved in regulation of NOX3 or NOX4 (26, 42) . However, in contrast to studies that claim NOX4 to be constitutively active, some recent reports suggest that NOX4 is, in fact, regulated (16) . In mesangial cells, NOX4 activation has been found to be part of a Rac1-dependent signaling pathway (12) . We found that inhibiting Rac1 blunted ANG II-induced O 2 Ϫ generation in the NOX4/siRNA-treated cells but not in the NOX2/siRNAtreated cells. Together, our results suggest that ANG II acts on AT1 receptors in the MD, leading to Rac1-dependent activa- . There are several possible explanations for this. First, because apocynin inhibits NOX in general, whereas the siRNA is specific for NOX2, the difference may be due to effects of ANG II on other NOX isoforms (which are not regulated by Rac). Moreover, apocynin has been reported to have antioxidant effects that are independent of NOX (15); thus it may be reducing O 2 Ϫ independent of NOX inhibition. Although we did not detect an alternative source, we did not evaluate sources such as cytochrome P-450 and mitochondria, or interactions between these and other sources (NOX4, xanthine oxidase, COX-2, uncoupled NOS). Alternatively, it may simply have been due to incomplete blockade by the NOX2 siRNA and the Rac1 inhibitor. However, regardless of these potential additional sources of O 2 Ϫ , our study suggests that ANG II primarily increases O 2 Ϫ production in MMDD1 cells, a MD-like cell line, via AT 1 -mediated activation of NOX2 and that this activation is at least partly dependent on Rac1.
Perspectives
For TGF to be effective under a wide range of acute and chronic physiologic perturbations, it has to be carefully modulated. Our data indicate that ANG II, via AT 1 -mediated activation NOX2 increases O 2 Ϫ production in the MD cells. This increase in O 2 Ϫ may in turn quench NO at the MD and thus enhance TGF responses, raising the possibility that Rac-enhanced increases in O 2 Ϫ may mediate the increased TGF sensitivity and abnormal sodium handling observed during conditions associated with elevated ANG II and oxidative stress such as hypertension, acute renal failure, and cirrhosis. Indeed, Welch (44) reported that the spontaneously hypertensive rat has increased oxidative stress, decreased NO signaling in the juxtaglomerular apparatus, and exaggerated TGF, all of which were improved by AT 1 receptor blockade, suggesting abnormal regulation of juxtaglomerular ANG II-induced oxidative stress in this experimental model of hypertension. Thus it is important to define the regulation of this pathway as well as identify the specific abnormalities that may lead to abnormal juxtaglomerular ANG II, oxidative stress, and Rac signaling, because this may lead to the identification of novel and more specific therapeutic targets.
